Q1 2026 M&A deal flow preview: mid-market is hot, solo practices aren't.

A dollar of annual profit is worth about $5 if it sits inside a single-location general practice and about $12 if it sits inside a DSO platform. That spread, not interest rates and not patient demand, is the entire story of Q1 2026 deal flow, and the buyers lining up this quarter are going to widen it.

Our view, stated plainly so you can argue with it: 2026 is shaping up to be the busiest dental M&A year since the 2021 peak, and the large majority of solo owners will get nothing out of it. Not a higher price, not more bidders, not a faster close. If you own one location doing under roughly $1 million in collections and you've been waiting for the private equity money to work its way down to your size, you're waiting at a bus stop the bus doesn't service. A solo practice isn't a small DSO. It's a job with good equipment and a waiting room.

One Dollar of Profit, Three Different Prices

Start with the pricing grid, because it does most of the arguing for us. In the year ending Q2 2026, CT Acquisitions reports solo owner-operator general practices under $500K SDE traded at 4.0x to 6.0x SDE. Multi-location DSO add-on targets in the $1.0M to $3.0M EBITDA band traded at 6.5x to 9.0x. Platform-tier targets above $10M EBITDA traded at 10.0x to 15.0x.

Read that as three separate markets wearing the same industry label. The solo band and the platform band don't compete for the same capital, don't run the same diligence, and don't price the same risk. A buyer paying 12x for a platform is buying a management team, a revenue cycle function, a recruiting pipeline, and a set of locations that keep producing when any one dentist takes a month off. A buyer paying 5x for a solo practice is buying goodwill attached to one person's hands, and discounting hard for the chance those hands walk out the door.

The gap isn't an inefficiency waiting to be arbitraged by the patient seller. It's a correct read on transferability. Nobody is going to wake up in March and decide that one-doctor goodwill is suddenly worth 9x.

Why the Capital Is Pointed at Groups

TUSK Practice Sales surveyed DSOs and found 61% of their private equity backers expect a moderate or high increase in 2026 acquisition activity versus 2025, with 78% anticipating a recapitalization within 12 to 36 months. Those two numbers belong together. A sponsor that intends to recap inside three years needs a story to tell the next buyer, and the story has to be growth that looks structural rather than lucky.

The cheapest version of that story is add-on math. Buy earnings at 7x, fold them into a platform that trades at 12x, and the spread shows up as enterprise value without a single new patient. That's why the 61% figure translates into pressure on the $1.0M to $3.0M EBITDA band specifically. Group practices in that range are the raw material of a recap.

Solo practices are bad raw material for that machine, and not because of snobbery. A one-location acquisition takes the same legal spend, the same payer re-credentialing slog, and the same IT cutover as a three-location acquisition, and delivers a third of the earnings. Worse, the integration risk is concentrated in a single provider who is also the person you just handed a check to. Corporate development teams measure deals in EBITDA per hour of their own time. On that measure, your practice loses to a group every time.

The volume signal supports it. TUSK closed an additional $23.8 million in transaction value for clients in Q1 2026 compared with Q1 2025. Dollars are moving. They're just not moving in $1.4 million increments.

What Most Owners Get Wrong: Mistaking Supply for Demand

Here's the specific error, and it's made most often by owners between 55 and 65 who run one location and have decided that 2027 or 2028 is the year. They browse broker listing sites, see hundreds of practices with asking prices attached, and conclude that a liquid market exists at their size. It's backwards. A listing page is supply. It tells you how many sellers want out, not how many buyers are competing.

Our own dataset makes the scale of that supply concrete. The Dental Signal Practice Market Index tracks 925 practices currently listed for sale. Among those listings, median collections run $957,588, with the middle half between $650,000 and $1,500,000 (n=753). General practices on the market show median collections of $946,000 (n=644). Median operatory count is 5 (n=754), and collections per operatory come in at a median $200,000 (n=643).

Those are the practices asking for a buyer, not the practices typical of the profession, and nothing in them tells you what anything sells for. What they do tell you is the shape of your competition. If you're a five-operatory general practice collecting just under a million, you are not a distinctive asset. You are the median of a very long queue, and you'll be negotiating against the other practices in that queue, not against a scarcity premium.

The second half of the mistake is assuming the traditional buyer is still out there. The ADA Health Policy Institute puts private practice ownership at 72.5% of U.S. dentists in 2023, down from 84.7% in 2005, with 16% of dentists affiliated with a DSO in 2024. The age breakdown is the part that should worry a solo seller: fewer than 1 in 10 dentists under 30 were practice owners as of 2021, and ownership among 30 to 34 year-olds fell from over 50% in 2005 to about one third by 2021.

The individual dentist who used to buy your practice with an SBA loan and a handshake is now an employee somewhere, with student debt and no interest in managing an aging compressor. That buyer pool is thinning every year while the listing queue grows. We wouldn't bet a retirement on it reversing.

Three Owners, One Merger, $870,000

So what do you do if you're on the wrong side of the grid? Change which market you're selling into. Here's the math, using a hypothetical that should feel familiar.

Take a solo general practice collecting $950,000 with a true owner benefit of 30% after a market-rate replacement wage for the doctor's clinical production. That's $285,000 of SDE. At the 5.0x midpoint of the solo band, the practice prices at $1,425,000. Call that the baseline outcome, and note that it assumes the practice sells at all, on the first listing, without a price cut.

Now take three of those owners in adjacent zip codes, all within five years of the same exit. Combined SDE is $855,000. Merge the entities, build the thing a buyer actually pays for (one administrator over all three sites, one payer contracting function, shared hygiene scheduling, consolidated supply purchasing), and carry the cost of that layer honestly at $120,000 a year. Pro forma EBITDA lands at $735,000.

That number sits squarely in the add-on band. At 7.0x, conservative against a 6.5x to 9.0x range, the combined group prices at $5,145,000. Three separate sales at $1,425,000 each total $4,275,000. The difference is $870,000, or $290,000 per owner.

It isn't free. Budget $150,000 across the three of you for legal structuring, a quality of earnings pre-audit, valuation work to settle relative contributions, and the accounting cleanup nobody enjoys. Net gain drops to $720,000, or $240,000 each. That's still a quarter of a million dollars per owner for eighteen to twenty-four months of genuinely annoying governance work, and it comes with a second benefit the spreadsheet misses: a group with $735,000 of EBITDA gets return calls from corporate development teams. A $285,000 SDE practice gets a form response.

Our call: if you're a solo owner within five years of exit and you have two peers in the same boat within driving distance, the merger conversation is worth more than any marketing initiative on your list this year. And if you can't find peers, the honest alternative is a seller-financed sale to an associate you start recruiting now, at a price you'll set yourself, because the open market isn't going to set a better one for you.

The Owner Who Should Be Buying, Not Selling

Flip the grid once more. If solo general practices are trading at 4.0x to 6.0x SDE and add-on groups at 6.5x to 9.0x, then the cheapest earnings in dentistry right now are sitting in single-location practices owned by dentists who want out and have no bidders. For a 45-year-old owner with one strong location, a functioning management layer, and access to credit, that's the opportunity of the cycle. Buy the second and third location at 5x from the thinning solo market, build the shared back office, and sell the combination into the band that 61% of private equity backers say they're expanding into.

That's the same arbitrage the platforms are running, executed one tier down. Nothing about it requires private equity backing. It requires willingness to own a business instead of a practice, which is precisely the willingness that the ownership data says is getting rarer.

What Would Change Our Mind

Two things. First, the 78% recap expectation is a forecast, not a closing. If platform recaps start failing to clear in the second half of 2026 because the next buyer won't pay 12x, add-on appetite dries up fast and the 6.5x floor on group deals compresses toward the solo band. In that world, waiting was right and merging was expensive theater. We'd watch add-on pricing on completed deals, not announced intentions.

Second, DSO affiliation at 16% of dentists still leaves most of the profession unconsolidated. If that share jumps sharply in the next two prints, the platforms will eventually run out of groups to buy and start working down the size curve to single locations out of necessity. That's the scenario where solo multiples finally move. We don't expect it inside 24 months, and we wouldn't plan an exit around it.

Three Calls to Make This Month

Pull your trailing twelve months and calculate true SDE with a market-rate wage subtracted for your own clinical production, because that's the number a buyer starts from and it's almost always lower than what owners assume. Then make a list of every single-location owner within 30 minutes of you who's inside five years of exit, and have the uncomfortable coffee with the two most plausible. If a merger isn't realistic, start the associate search now and price a ten-year note, because a buyer you train is worth more than a buyer you wait for.

Before any of those conversations, get your own valuation range on paper so you're not negotiating off a broker's opinion. Our valuation calculator runs the SDE and multiple math on your actual collections and overhead in a few minutes, and it will tell you quickly whether you're pricing into the solo band or close enough to the add-on tier to make a group play worth the legal bill. Run your own numbers, then go have the coffee.